Sasaki N - Search Results

1

Normal serum CA125 half-life and normal serum nadir CA125 level in patients with ovarian cancers.

Yoshikawa T, Takano M, Kita T, Kudoh K, Sasaki N, Kato M, Watanabe A, Miyamoto M, Goto T, Furuya K. Yoshikawa T, et al. Among authors: sasaki n. Eur J Gynaecol Oncol. 2012;33(3):269-73. Eur J Gynaecol Oncol. 2012. PMID: 22873097

2

Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study.

Takano M, Kato M, Yoshikawa T, Sasaki N, Hirata J, Furuya K, Takahashi M, Yokota H, Kino N, Horie K, Goto T, Fujiwara K, Ishii K, Kikuchi Y, Kita T. Takano M, et al. Among authors: sasaki n. Oncology. 2009;76(5):315-21. doi: 10.1159/000209335. Epub 2009 Mar 20. Oncology. 2009. PMID: 19299905

3

Large cell neuroendocrine carcinoma arising in mature cystic teratoma: a case report and review of the literature.

Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Furuya K. Miyamoto M, et al. Among authors: sasaki n. Eur J Gynaecol Oncol. 2012;33(4):414-8. Eur J Gynaecol Oncol. 2012. PMID: 23091901 Review.

4

Prognosis of high-grade endometrial cancer: a comparison of serous-type and clear cell type to grade 3 endometrioid-type.

Goto T, Takano M, Aoyama T, Miyamoto M, Watanabe A, Kato M, Sasaki N, Hirata J, Sasa H, Furuya K. Goto T, et al. Among authors: sasaki n. Eur J Gynaecol Oncol. 2012;33(6):579-83. Eur J Gynaecol Oncol. 2012. PMID: 23327049

5

Complete remission of recurrent and refractory ovarian cancers using weekly administration of bevacizumab and gemcitabine/oxaliplatin: report of two cases.

Takano M, Ikeda Y, Kudoh K, Kita T, Sasaki N, Kikuchi Y. Takano M, et al. Among authors: sasaki n. Eur J Gynaecol Oncol. 2013;34(1):90-3. Eur J Gynaecol Oncol. 2013. PMID: 23590010

6

Ovarian yolk sac tumor associated with pregnancy: a case report and review of the literature.

Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Furuya K. Miyamoto M, et al. Among authors: sasaki n. Eur J Gynaecol Oncol. 2014;35(6):738-40. Eur J Gynaecol Oncol. 2014. PMID: 25556285 Review.

7

[The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma].

Fujii K, Okamoto S, Saitoh K, Sasaki N, Takano M, Tanaka S, Kudoh K, Kita T, Tode T, Kikuchi Y. Fujii K, et al. Among authors: sasaki n. Gan To Kagaku Ryoho. 2004 Oct;31(10):1537-40. Gan To Kagaku Ryoho. 2004. PMID: 15508446 Japanese.

8

[Clinical study on the efficacy of weekly paclitaxel administration for platinum-resistant epithelial ovarian carcinoma].

Fujii K, Takano M, Okamoto S, Sasaki N, Kita T, Kikuchi Y. Fujii K, et al. Among authors: sasaki n. Gan To Kagaku Ryoho. 2004 Dec;31(13):2141-4. Gan To Kagaku Ryoho. 2004. PMID: 15628759 Japanese.

9

Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma.

Sasaki N, Kudoh K, Kita T, Tsuda H, Furuya K, Kikuchi Y. Sasaki N, et al. J Obstet Gynaecol Res. 2007 Feb;33(1):17-23. doi: 10.1111/j.1447-0756.2007.00486.x. J Obstet Gynaecol Res. 2007. PMID: 17212661

10

Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging.

Takano M, Sasaki N, Kita T, Kudoh K, Fujii K, Yoshikawa T, Kato M, Hirata J, Furuya K, Tsuda H, Kikuchi Y. Takano M, et al. Among authors: sasaki n. Oncol Rep. 2008 May;19(5):1259-64. Oncol Rep. 2008. PMID: 18425385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,498 results

Search Page

Filters